Exor
68,10 €Variación respecto al cierre anterior: +0,37 %Variación absoluta: +0,25 €
En resumen
- Margen neto
- 107,8 %
- 2024: 95,3 %
Datos financieros
Importes en millones de EUR; valores por acción en EUR; acciones en millones.
| Partida | T2 2026 | T4 2025 | T2 2025 | T4 2024 | T2 2024 | T4 2023 | T2 2023 | T4 2022 | T2 2022 | T4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos totales | -1.072 | -2.961 | -557 | 255 | 15.140 | 24.038 | 21.367 | 23.161 | 18.683 | 17.477 |
| Coste de ventas | — | — | — | — | — | 17.589 | 15.317 | 17.628 | 14.087 | 13.336 |
| Beneficio bruto | -1.072 | -2.961 | -557 | 255 | 15.140 | 6.449 | 5.522 | 5.161 | 4.344 | 3.817 |
| Gastos generales, de venta y administración | 25,0 | 56,0 | 25,0 | 35,0 | 20,0 | 1.772 | 1.743 | 1.827 | 1.493 | 1.429 |
| Investigación y desarrollo | — | — | — | — | — | 1.328 | 1.145 | 1.084 | 989 | 934 |
| Resultado operativo | -1.097 | -3.015 | -582 | 220 | 15.120 | 3.349 | 2.634 | 2.250 | 1.862 | 1.454 |
| EBIT | -1.097 | -3.015 | -582 | 220 | 15.120 | 3.349 | 2.634 | 2.250 | 1.862 | 1.454 |
| EBITDA | — | — | — | 1.245 | 16.145 | 4.441 | 3.592 | 2.397 | 2.755 | 1.522 |
| Gastos financieros | 61,0 | 32,0 | 68,0 | 67,0 | 56,0 | — | 247 | 744 | 238 | 65,0 |
| Beneficio antes de impuestos | -1.114 | -3.081 | -614 | 42,0 | 14.720 | 3.777 | 4.095 | 3.220 | 2.676 | 2.258 |
| Impuestos | 8,0 | 88,0 | 10,0 | 66,0 | 25,0 | 487 | 608 | 554 | 506 | 913 |
| Beneficio neto | -1.122 | -3.169 | -624 | -24,0 | 14.695 | 2.037 | 2.157 | 3.962 | 265 | 879 |
| Beneficio neto para accionistas ordinarios | -1.122 | -3.169 | -624 | -24,0 | 14.695 | 2.037 | 2.157 | 3.962 | 265 | 879 |
| BPA básico | -5,54 | -15,63 | -3,01 | -0,11 | 68,14 | 9,18 | 9,54 | 17,30 | 1,15 | 4,20 |
| BPA diluido | -5,54 | -15,63 | -3,01 | -0,11 | 66,99 | 8,99 | 9,39 | 16,87 | 1,14 | 4,20 |
| Acciones medias (básicas) | 202 | 203 | 208 | 214 | 216 | 222 | 226 | 229 | 231 | 209 |
| Acciones medias (diluidas) | 202 | 203 | 208 | 219 | 219 | 226 | 230 | 235 | 232 | 209 |
